Diferencia entre revisiones de «Salmonella»

(Text replacement - "*Diarrhea" to "*Diarrhea")
(Add Ciprofloxacin, Azithromycin, Amoxicillin AntibioticDose entries)
 
(No se muestran 3 ediciones intermedias de 2 usuarios)
Línea 1: Línea 1:
==Background==
==Background==
*Salmonella enteritidis is a common cause of food borne disease outbreaks
*''Salmonella enteritidis'' is a common cause of food borne disease outbreaks
*[[Gram negative]] rod
*Infection commonly from foodborne transmission
*Infection commonly from foodborne transmission
*Associated with poultry/hen eggs, peanut butter
*Associated with poultry/hen eggs, peanut butter
Línea 45: Línea 46:
***Duration should be 14 days in immunocompromised
***Duration should be 14 days in immunocompromised
**Children:
**Children:
***Ceftriaxone 100mg/kg/day divided into two doses x 7-10 days
***[[Ceftriaxone]] 100mg/kg/day divided into two doses x 7-10 days
***Azithromycin 20mg/kg/day daily x 7 days
***Azithromycin 20mg/kg/day daily x 7 days


Línea 193: Línea 194:
===Key===
===Key===
{{Template:Antibacterial Spectra Key}}
{{Template:Antibacterial Spectra Key}}
===Antibiotic Dosing===
====Adult====
*{{AntibioticDose|drug=Ciprofloxacin|dose='''Acute'''; 500-750mg PO q12h x 3-7 days; Extend treatment x 1 week if immunocompromised; '''Chronic Carrier'''; 750mg PO q12h x 1 month|context=Salmonella|disease=Salmonella|population=Adult}}
*{{AntibioticDose|drug=Azithromycin|dose=1 g PO q24h x1 day, then 500mg PO q24h x2-6 days|context=Salmonella|disease=Salmonella|population=Adult}}
*{{AntibioticDose|drug=Amoxicillin|dose=''Not 1st line treatment''; Acute; Immunocompetent; 500mg PO q8h x 3-7 days; Immunocompromised; 1000mg PO q8h x 3-14 days; Chronic carrier; 1000mg PO q8h x 3 months|context=Salmonella|disease=Salmonella|population=Adult}}
====Pediatric====
*{{AntibioticDose|drug=Amoxicillin|dose=50-100mg/kg/day PO divided q8-12h; Acute: x 3-7 days; Acute Immunocompromised: 10-14 days; Chronic: 3 months|context=Salmonella (>3mo)|disease=Salmonella|population=Pediatric}}


==Table Overview==
==Table Overview==

Revisión actual - 11:00 20 mar 2026

Background

  • Salmonella enteritidis is a common cause of food borne disease outbreaks
  • Gram negative rod
  • Infection commonly from foodborne transmission
  • Associated with poultry/hen eggs, peanut butter
  • Seen in infants often due to cross-contamination in household

Clinical Features

  • Severity dependent on dose ingested
  • Symptoms within 8-72 hours
  • Course: Fever resolves within 48-72 hours; diarrhea resolves within 4-10 days
  • < 5% of patients develop bacteremia that is rarely complicated by endocarditis, osteomyelitis, or mycotic aneurysm.
  • Mortality < 0.5-1%

Differential Diagnosis

Acute diarrhea

Infectious

Noninfectious

Watery Diarrhea

Traveler's Diarrhea

Evaluation

  • Stool culture

Management

Supportive care

  • IVF

Antibiotics

  • Have not been shown to reduce duration of symptoms and not recommended in:[2][3]
    • Mild-moderate infection
    • Immunocompetent
    • Patients aged 2-50 years old
  • Antibiotics may have a role in patients with:[4]
    • Severe illness
    • IBD
    • Immunocompromised
    • Steroid use
    • < 3 months or > 65 years old
    • On hemodialysis
    • Sickle cell disease
  • Recommended regimens:[5]
    • Adults:
      • Levofloxacin (or other fluoroquinolone) 500mg daily x 7-10 days
      • Azithromycin 500mg daily x 7 days
      • Duration should be 14 days in immunocompromised
    • Children:
      • Ceftriaxone 100mg/kg/day divided into two doses x 7-10 days
      • Azithromycin 20mg/kg/day daily x 7 days

Antibiotic Sensitivities[6]

Category Antibiotic Sensitivity
Penicillins Penicillin G R
Penicillin V R
Anti-Staphylocccal Penicillins Methicillin R
Nafcillin/Oxacillin R
Cloxacillin/Diclox. R
Amino-Penicillins AMP/Amox I
Amox-Clav S
AMP-Sulb S
Anti-Pseudomonal Penicillins Ticarcillin S
Ticar-Clav S
Pip-Tazo S
Piperacillin S
Carbapenems Doripenem S
Ertapenem S
Imipenem S
Meropenem S
Aztreonam X1
Fluroquinolones Ciprofloxacin S
Ofloxacin S
Pefloxacin S
Levofloxacin S
Moxifloxacin S
Gemifloxacin X1
Gatifloxacin S
1st G Cephalo Cefazolin X1
2nd G. Cephalo Cefotetan X1
Cefoxitin X1
Cefuroxime X1
3rd/4th G. Cephalo Cefotaxime S
Cefizoxime S
CefTRIAXone S
Ceftaroline S
CefTAZidime S
Cefepime S
Oral 1st G. Cephalo Cefadroxil R
Cephalexin R
Oral 2nd G. Cephalo Cefaclor/Loracarbef X1
Cefproxil X1
Cefuroxime axetil X1
Oral 3rd G. Cephalo Cefixime S
Ceftibuten S
Cefpodox/Cefdinir/Cefditoren S
Aminoglycosides Gentamicin X1
Tobramycin X1
Amikacin X1
Chloramphenicol S
Clindamycin R
Macrolides Erythromycin R
Azithromycin I
Clarithromycin R
Ketolide Telithromycin R
Tetracyclines Doxycycline I
Minocycline I
Glycylcycline Tigecycline S
Daptomycin R
Glyco/Lipoclycopeptides Vancomycin R
Teicoplanin R
Telavancin R
Fusidic Acid R
Trimethoprim I
TMP-SMX I
Urinary Agents Nitrofurantoin S
Fosfomycin S
Other Rifampin R
Metronidazole R
Quinupristin dalfoppristin R
Linezolid R
Colistimethate X1

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia


Antibiotic Dosing

Adult

  • Ciprofloxacin Acute; 500-750mg PO q12h x 3-7 days; Extend treatment x 1 week if immunocompromised; Chronic Carrier; 750mg PO q12h x 1 month
  • Azithromycin 1 g PO q24h x1 day, then 500mg PO q24h x2-6 days
  • Amoxicillin Not 1st line treatment; Acute; Immunocompetent; 500mg PO q8h x 3-7 days; Immunocompromised; 1000mg PO q8h x 3-14 days; Chronic carrier; 1000mg PO q8h x 3 months

Pediatric

  • Amoxicillin 50-100mg/kg/day PO divided q8-12h; Acute: x 3-7 days; Acute Immunocompromised: 10-14 days; Chronic: 3 months

Table Overview

References

  1. Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
  2. Onwuezobe, I. A., Oshun, P. O., & Odigwe, C. C. (2012). Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. The Cochrane database of systematic reviews, , CD001167.
  3. DuPont, H. L. (2014). Acute infectious diarrhea in immunocompetent adults. The New England journal of medicine, 16, 1532–1540.
  4. DuPont HL. Bacterial diarrhea. N Engl J Med 2009;361:1560-9.
  5. DuPont HL. Bacterial diarrhea. N Engl J Med 2009;361:1560-9.
  6. Sanford Guide to Antimicrobial Therapy 2014

See Also

References